rdf:type |
|
lifeskim:mentions |
umls-concept:C0002395,
umls-concept:C0008425,
umls-concept:C0016410,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0087162,
umls-concept:C0301532,
umls-concept:C0332256,
umls-concept:C0599724,
umls-concept:C1417635,
umls-concept:C1420797,
umls-concept:C1515075,
umls-concept:C1556096,
umls-concept:C2825951
|
pubmed:issue |
10
|
pubmed:dateCreated |
2007-11-28
|
pubmed:abstractText |
Elevated serum homocysteine levels have been associated with the development of Alzheimer's dementia (AD). The combined use of a mecobalamin capsule preparation, which contains vitamin B12 0.5 mg with an active methyl base, and an over-the-counter nutritional supplement that contains folic acid 1 mg and pyridoxine hyperchloride 5 mg may be effective as a homocysteine-lowering vitamin regimen.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2204-14
|
pubmed:meshHeading |
pubmed-meshheading:18042476-Aged,
pubmed-meshheading:18042476-Alzheimer Disease,
pubmed-meshheading:18042476-Asian Continental Ancestry Group,
pubmed-meshheading:18042476-Cholinesterase Inhibitors,
pubmed-meshheading:18042476-Double-Blind Method,
pubmed-meshheading:18042476-Drug Therapy, Combination,
pubmed-meshheading:18042476-Female,
pubmed-meshheading:18042476-Folic Acid,
pubmed-meshheading:18042476-Homocysteine,
pubmed-meshheading:18042476-Humans,
pubmed-meshheading:18042476-Indans,
pubmed-meshheading:18042476-Male,
pubmed-meshheading:18042476-Piperidines,
pubmed-meshheading:18042476-Taiwan,
pubmed-meshheading:18042476-Vitamin B 12,
pubmed-meshheading:18042476-Vitamin B 6,
pubmed-meshheading:18042476-Vitamin B Complex
|
pubmed:year |
2007
|
pubmed:articleTitle |
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.
|
pubmed:affiliation |
Department of Neurology, En Chu Kong Hospital, San-shia, Taipei, Taiwan. sunyu@ms4.hinet.net
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|